Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Palmsten

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Arthritis Care & Research|January 28, 2022
Differences in the Association Between Oral Glucocorticoids and Risk of Preterm Birth by Data Source: Reconciling the ResultsKristin Palmsten, Gretchen Bandoli, Gabriela Vazquez-Benitez, et al.
Rheumatic Diseases Clinics of North America|July 17, 2017
A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth OutcomesGretchen Bandoli, Kristin Palmsten, Chelsey J Forbess Smith, et al.
Rheumatology (Oxford, England)|December 26, 2016
Medication use among pregnant women with systemic lupus erythematosus and general population comparatorsKristin Palmsten, Julia F Simard, Christina D Chambers, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 25, 2019
Asthma prevalence among women aged 18 to 44 in the United States: National health and nutrition examination survey 2001-2016Katrina F Flores, Gretchen Bandoli, Christina D Chambers, et al.
American Journal of Obstetrics and Gynecology|April 9, 2023
Association between hypertensive disorders of pregnancy and cardiovascular diseases within 24 months after deliveryChristina M Ackerman-Banks, Heather S Lipkind, Kristin Palmsten, et al.
Arthritis Care & Research|November 1, 2012
Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsiaKristin Palmsten, Sonia Hernández-Díaz, Bindee Kuriya, et al.
American Journal of Obstetrics & Gynecology MFM|January 4, 2025
Prevalence of GLP-1 medication exposure prior to, during, and after pregnancy using state-wide data from 2017 to 2023Katherine A Ahrens, Kristin Palmsten, Heather S Lipkind, et al.
American Journal of Obstetrics & Gynecology MFM|April 5, 2024
Association between gestational diabetes and cardiovascular disease within 24 months postpartumChristina M Ackerman-Banks, Kristin Palmsten, Heather S Lipkind, et al.
American Journal of Epidemiology|March 24, 2012
Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?Kristin Palmsten, Soko Setoguchi, Andrea V Margulis, et al.
Pharmacoepidemiology and Drug Safety|December 22, 2019
Using nationally representative survey data for external adjustment of unmeasured confounders: An example using the NHANES dataSonia Hernández-Díaz, Brian T Bateman, Kristin Palmsten, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Arthritis Care & Research|January 28, 2022
Differences in the Association Between Oral Glucocorticoids and Risk of Preterm Birth by Data Source: Reconciling the ResultsKristin Palmsten, Gretchen Bandoli, Gabriela Vazquez-Benitez, et al.
Rheumatic Diseases Clinics of North America|July 17, 2017
A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth OutcomesGretchen Bandoli, Kristin Palmsten, Chelsey J Forbess Smith, et al.
Rheumatology (Oxford, England)|December 26, 2016
Medication use among pregnant women with systemic lupus erythematosus and general population comparatorsKristin Palmsten, Julia F Simard, Christina D Chambers, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 25, 2019
Asthma prevalence among women aged 18 to 44 in the United States: National health and nutrition examination survey 2001-2016Katrina F Flores, Gretchen Bandoli, Christina D Chambers, et al.
American Journal of Obstetrics and Gynecology|April 9, 2023
Association between hypertensive disorders of pregnancy and cardiovascular diseases within 24 months after deliveryChristina M Ackerman-Banks, Heather S Lipkind, Kristin Palmsten, et al.
Arthritis Care & Research|November 1, 2012
Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsiaKristin Palmsten, Sonia Hernández-Díaz, Bindee Kuriya, et al.
American Journal of Obstetrics & Gynecology MFM|January 4, 2025
Prevalence of GLP-1 medication exposure prior to, during, and after pregnancy using state-wide data from 2017 to 2023Katherine A Ahrens, Kristin Palmsten, Heather S Lipkind, et al.
American Journal of Obstetrics & Gynecology MFM|April 5, 2024
Association between gestational diabetes and cardiovascular disease within 24 months postpartumChristina M Ackerman-Banks, Kristin Palmsten, Heather S Lipkind, et al.
American Journal of Epidemiology|March 24, 2012
Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?Kristin Palmsten, Soko Setoguchi, Andrea V Margulis, et al.
Pharmacoepidemiology and Drug Safety|December 22, 2019
Using nationally representative survey data for external adjustment of unmeasured confounders: An example using the NHANES dataSonia Hernández-Díaz, Brian T Bateman, Kristin Palmsten, et al.
Pageof 9